These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36128856)

  • 1. MitraClip™ implantation plus left atrial appendage occlusion in a hereditary hemorrhagic telangiectasia patient.
    D'Alessandro P; Tritto R; Cillis E; Acquaviva T; Giordano A; Nestola PL; Pepe M; Bortone AS
    Future Cardiol; 2022 Nov; 18(11):849-855. PubMed ID: 36128856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined MitraClip implantation and left atrial appendage occlusion using the Watchman device: A case series from a referral center.
    Francisco ARG; Infante de Oliveira E; Nobre Menezes M; Carrilho Ferreira P; Canas da Silva P; Nobre Â; Pinto FJ
    Rev Port Cardiol; 2017; 36(7-8):525-532. PubMed ID: 28673783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left atrial appendage occlusion with the Watchman device in a patient with paroxysmal atrial fibrillation and intolerance of all forms of anticoagulation due to hereditary haemorrhagic telangiectasia.
    Spina R; Gunalingam B
    Intern Med J; 2014 Mar; 44(3):295-7. PubMed ID: 24621286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombotic therapy for atrial fibrillation in hereditary hemorrhagic telangiectasia.
    Virk ZM; Richardson TL; Al-Samkari H
    J Thromb Thrombolysis; 2023 Aug; 56(2):355-359. PubMed ID: 37340288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation and contraindication for anticoagulation.
    Grosset-Janin D; Barth E; Bertrand B; Detante O
    Rev Neurol (Paris); 2015 May; 171(5):426-32. PubMed ID: 25912470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of reduced or absent antithrombotic therapy after left atrial appendage closure in patients affected by hereditary hemorrhagic telangiectasia and atrial fibrillation.
    Pepe M; Suppressa P; Giuliano AF; Nestola PL; Bortone AS; DE Cillis E; Acquaviva T; Forleo C; Moscarelli M; Lenato GM; Sabbà C
    Minerva Cardiol Angiol; 2022 Oct; 70(5):537-544. PubMed ID: 33703853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility of concomitant exclusion of left atrial appendage during novel transapical off-pump beating heart mitral valve repair.
    Chan DT; Bhatia I; Lam SC; Au TW
    J Artif Organs; 2024 Mar; 27(1):57-64. PubMed ID: 36752993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combined percutaneous procedure of mitral valve repair with the edge-to-edge technique and left atrial appendage occlusion].
    D'Amico G; Fabris T; Fraccaro C; Tarantini G
    G Ital Cardiol (Rome); 2019 Mar; 20(3 Suppl 1):35S-39S. PubMed ID: 30855031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous left atrial appendage closure: in a patient with hereditary hemorrhagic telangiectasia and atrial fibrillation.
    Brenna EJ; Bethencourt A; Contreras AE; Ballarino MA; Peirone A
    Tex Heart Inst J; 2011; 38(5):604-5. PubMed ID: 22163150
    [No Abstract]   [Full Text] [Related]  

  • 10. Left Atrial Appendage Occlusion in Hereditary Haemorrhagic Telangiectasia Patients (Rendu Osler Syndrome) With Non-Valvular Atrial Fibrillation: Prevention of Cardioembolic Events While Avoiding the Long-Term Risks of Oral Anticoagulation.
    Cepas-Guillen PL; López-Mínguez JR; García JCN; Nombela-Franco L; Benito-González T; Cruz-González I; Freixa X
    Cardiovasc Revasc Med; 2022 Oct; 43():140-142. PubMed ID: 35513968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Anterior Mitral Valve Leaflet Mechanical Erosion Following Left Atrial Appendage Occluder Implantation.
    Berrebi A; Sebag FA; Diakov C; Amabile N
    JACC Cardiovasc Interv; 2017 Aug; 10(16):1708-1709. PubMed ID: 28780031
    [No Abstract]   [Full Text] [Related]  

  • 12. [Percutaneous left atrial appendage closure in a patient with atrial fibrillation and Rendu-Osler-Weber disease].
    Bosi D; Cozza F; Menozzi A; Lina D; Guidorossi A; Benatti G; Cattabiani MA; Vignali L
    G Ital Cardiol (Rome); 2019 Apr; 20(4 Suppl 1):36S-39S. PubMed ID: 30994632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left Atrial Appendage Occlusion for Patients with Transcatheter Aortic Valve Replacement, MitraClip, Percutaneous Coronary Intervention, and Ablation for Atrial Fibrillation: Optimizing Long-Term Patient Outcomes.
    Krishnaswamy A; Wazni O; Kapadia SR
    Card Electrophysiol Clin; 2020 Mar; 12(1):117-124. PubMed ID: 32067641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late MitraClip procedure after left atrial appendage occlusion: indication and procedure description.
    Cammalleri V; Scandura S; Tamburino C; Ussia GP
    Catheter Cardiovasc Interv; 2014 Feb; 83(2):291-6. PubMed ID: 23436381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary artery obstruction during mitral valve surgery and concomitant left atrial appendage exclusion; choosing a culprit.
    Gerdisch MW
    J Card Surg; 2022 Aug; 37(8):2506. PubMed ID: 35575412
    [No Abstract]   [Full Text] [Related]  

  • 16. Bilateral atrial appendage aneurysms associated with atrial fibrillation.
    Nakahara T; Minakata K; Yamazaki K; Funamoto M; Sakata R
    Asian Cardiovasc Thorac Ann; 2014 Mar; 22(3):347-9. PubMed ID: 24585916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous left atrial appendage closure in patients with primary hemostasis disorders and atrial fibrillation.
    Dognin N; Salaun E; Champagne C; Domain G; O'Hara G; Philippon F; Paradis JM; Faroux L; Beaudoin J; O'Connor K; Bernier M; Rodés-Cabau J; Champagne J
    J Interv Card Electrophysiol; 2022 Aug; 64(2):497-509. PubMed ID: 34822043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergency surgical retrieval of a migrated LAmbre device through the mitral valve.
    Martinez-Lopez D; de Villarreal Soto JE; Mosquera VMO; Gil AF
    Eur J Cardiothorac Surg; 2021 Dec; 60(6):1475-1476. PubMed ID: 34331063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous left atrial appendage closure in a patient with atrial fibrillation and osler-weber-rendu disease.
    Gancarczyk U; Podolec P; Przewłocki T; Prochownik P; Komar M
    Wiad Lek; 2019 Oct; 72(10):2060-2062. PubMed ID: 31983153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemodynamic effects of percutaneous mitral valve edge-to-edge repair in patients with end-stage heart failure awaiting heart transplantation.
    Geis NA; Pleger ST; Bekeredjian R; Chorianopoulos E; Kreusser MM; Frankenstein L; Ruhparwar A; Katus HA; Raake PWJ
    ESC Heart Fail; 2018 Oct; 5(5):892-901. PubMed ID: 30058757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.